An Evolutionary Conserved Gene with an Expanding Repertoire of RNA Degradation Functions

Total Page:16

File Type:pdf, Size:1020Kb

An Evolutionary Conserved Gene with an Expanding Repertoire of RNA Degradation Functions Oncogene (2011) 30, 1733–1743 & 2011 Macmillan Publishers Limited All rights reserved 0950-9232/11 www.nature.com/onc REVIEW Human polynucleotide phosphorylase (hPNPaseold-35): an evolutionary conserved gene with an expanding repertoire of RNA degradation functions SK Das1, SK Bhutia1, UK Sokhi1, R Dash1, B Azab1, D Sarkar1,2,3 and PB Fisher1,2,3 1Department of Human and Molecular Genetics, Virginia Commonwealth University, School of Medicine, Richmond, VA, USA; 2VCU Institute of Molecular Medicine, Virginia Commonwealth University, School of Medicine, Richmond, VA, USA and 3VCU Massey Cancer Center, Virginia Commonwealth University, School of Medicine, Richmond, VA, USA Human polynucleotide phosphorylase (hPNPaseold-35)is eukaryotic cells, a variety of ribonucleases(RNases) act an evolutionary conserved RNA-processing enzyme cooperatively, initially shortening the 30 poly (A) tail of with expanding roles in regulating cellular physiology. an mRNA by deadenylases followed by the removal of hPNPaseold-35 was cloned using an innovative ‘overlapping the 50 cap structure by a decapping enzyme, which pathway screening’ strategy designed to identify genes enables the degradation of the transcript by a 50-30 coordinately regulated during the processes of cellular exoribonuclease. Alternatively, the mRNA might be differentiation and senescence. Although hPNPaseold-35 degraded from the 30 end by the cytoplasmic exosome, a structurally and biochemically resembles PNPase of other multiprotein complex of diverse 30-50 exoribo- species, overexpression and inhibition studies reveal that nucleases. Polynucleotide phosphorylase (PNPase) is a hPNPaseold-35 has evolved to serve more specialized and 30-50 exoribonuclease that uses the phosphorolytic diversified functions in humans. Targeting specific mRNA mechanism to degrade RNA (Mohanty and Kushner, or non-coding small microRNA, hPNPaseold-35 modulates 2000; Yehudai-Resheff et al., 2001; Sarkar et al., 2006). gene expression that in turn has a pivotal role in regula- It is conserved evolutionarily and is expressed in ting normal physiological and pathological processes. In different species including bacteria, plants, worms, flies, these contexts, targeted overexpression of hPNPaseold-35 mice and humans. Our group cloned the human represents a novel strategy to selectively downregulate homolog of polynucleotide phosphorylase (hPNPaseold-35) RNA expression and consequently intervene in a variety of in the unique contexts of differentiation and senescence, pathophysiological conditions. using an ‘overlapping pathway screening’ scheme. We Oncogene (2011) 30, 1733–1743; doi:10.1038/onc.2010.572; documented that hPNPaseold-35 has a key role in published online 13 December 2010 regulating both of these fundamental physiological processes (Leszczyniecka et al., 2002, 2003, 2004; Sarkar Keywords: hPNPaseold-35; senescence; RNA degradation; et al., 2003, 2004, 2005, 2006, 2007; Sarkar and Fisher, c-myc; miRNA 2006). We presently review recent advances in our understanding of hPNPaseold-35-mediated RNA degrada- tion, in particular its ability to target different classes of RNAs. Introduction RNA degradation and/turnover are major processes Cloning, expression and localization of hPNPaseold-35 controlling RNA levels and are important regulators of physiological and pathological processes (Parker and hPNPaseold-35 was cloned by using an overlapping Song, 2004). Labile messenger RNAs to more stable pathway screening approach (Leszczyniecka et al., non-coding RNAs (mostly ribosomal RNA and transfer 2002) during a screen for genes upregulated in the RNA, but also the expanding class of small regula- process of terminal cellular differentiation and senes- tory RNAs) are eventually degraded by a complex cence. Although terminal cell differentiation and cellular process involving the simultaneous or sequential inter- senescence represent two discrete phenomena, these play of multiple proteins. Many of these proteins are processes have several common characteristics. Both evolutionary conserved extending from prokaryotes to are distinguished by irreversible growth arrest associated higher mammals and serving comparable functions. In with marked inhibition of DNA synthesis, inhibition of telomerase activity and modulation of discrete programs Correspondence: Dr PB Fisher, Department of Human and Molecular of gene expression, especially upregulation of cyclin- Genetics, VCU Institute of Molecular Medicine, VCU Massey Cancer dependent kinase inhibitors (Fisher et al., 1985, 1986; Center, Virginia Commonwealth University, School of Medicine, 1101 Campisi, 1992). Combined treatment of metastatic East Marshall Street, Sanger Hall Building, Room 11-015, Richmond, human melanoma cells HO-1 with recombinant human VA 23298-0033, USA. E-mail: pbfi[email protected] fibroblast interferon (IFN)-b and the protein kinase C Received 1 September 2010; revised 20 October 2010; accepted 30 activator mezerein induces irreversible growth arrest October 2010; published online 13 December 2010 accompanied by morphological, biochemical, antigenic Human polynucleotide phosphorylase and RNA degradation SK Das et al 1734 and gene expression changes culminating in a state of mitochondrial localization signal at the NH2-terminal ‘terminal differentiation (Fisher and Grant, 1985; Fisher and it is imported into the mitochondria by i-AAA et al., 1985, 1986; Guarini et al., 1989, 1992; Jiang et al., (ATPases associated with several diverse cellular acti- 1993, 1995). Screening of a temporal complementary vities) protease Yme1, localized into mitochondrial DNA library generated from terminally differentiated intermembrane space and maintains mitochondrial HO-1 melanoma cells with complementary DNAs from homeostasis (Chen et al., 2006). However, our studies senescent progeriod fibroblasts identified 75 genes, document that overexpressed C-terminal HA-tagged termed old-1 to -75, which were upregulated during hPNPaseold-35 localizes both in cytosol and mitochondria both terminal differentiation and senescence. Sequence (Sarkar et al., 2005) indicating that hPNPaseold-35 might analysis of one particular clone, old-35, confirmed its reside within or outside mitochondria. In these contexts, identity to the PNPase gene, resulting in the gene being the targets and the consequences of hPNPaseold-35 renamed hPNPaseold-35 (Leszczyniecka et al., 2002). expression in different cellular compartments may be The hPNPaseold-35 gene consists of 28 exons and 27 distinct and diverse, thereby expanding the repertoire of introns spanning 54 kb in chromosome 2p15–2p16.1 activities of this interesting enzyme. (Leszczyniecka et al., 2003). Of interest, this unstable genomic region is prone to cytogenetic alterations in human cancers and in various genetic disorders RNA degradation machinery: PNPase and exosome (Kirschner et al., 1999) such as B-cell lymphoma (Fukuhara et al., 2006), type I hereditary nonpolyposis RNases are enzymes that are master regulators of colorectal cancer, familial male precocious puberty, stability and decay of RNA (Deutscher, 1993a, b; Carney complex, Doyne’s honeycomb retinal dystrophy Allmang et al., 1999; Deutscher and Li, 2001). Depend- and DYX-3, a form of familial dyslexia (Kirschner et al., ing on their degradative properties, RNases are divided 1999). hPNPaseold-35 mRNA expression could be into two functional classes, endoribonucleases that detected in all normal tissues analyzed with the cleave RNA molecules internally and exoribonucleases highest expression being detected in heart and brain that act at the end of RNA chains (Deutscher, 1993b). (Leszczyniecka et al., 2002). However, to date, there is RNA decay pathways in two of the most comprehen- no evidence linking expression and function of hPNPase sively studied model systems, the prokaroyte Escherichia to any of the aforementioned pathological processes. coli and the eukaryote Saccharomyces cerevisiae, are In bacteria, PNPase autogenously regulates its ex- different. In eukaryotes exoribonucleases can degrade pression by promoting the decay of PNPase mRNA by RNA both at 50–30 and 30–50 directions (Deutscher and binding to the 50-untranslated leader region of an RNase Li, 2001), whereas in prokaryotes RNA degradation III-processed form of this transcript (Jarrige et al., takes place only in the 30–50direction. However, an interest- 2001). To date the only known regulators of hPNPaseold-35 ing aspect of RNA decay in both prokaryotes and transcription are type I IFN (IFN-a and IFN-b) in both eukaryotes is the presence of multiprotein complexes normal and cancer cells with diverse backgrounds known as the degradosome and the exosome, respectively. irrespective of their p53 and Rb status (Leszczyniecka In E. coli, PNPase is associated with the endonuclease et al., 2002). Double-stranded RNA and poly(I) RNase E, RNA helicase and the glycolytic enzyme poly(C), a known inducer of IFN-a and IFN-b, also enolase to form the degradosome and executes its stimulate hPNPaseold-35 expression while IFN-g and processive 30–50 phosphorolysis or degradation of tumor necrosis factor-a have minimal or no effect, RNA species on endonucleolytic cleavage by RNase E. respectively. hPNPaseold-35 is an early IFN response gene PNPase acts as an integral component of degradosome and its induction depends on the Janus-activated kinase/ like RNA-helicase and enolase. In contrast, in yeast, signal transducers and activators of transcription signal PNPase is absent and the exosome, a complex of transduction pathways.
Recommended publications
  • Supplementary Materials
    DEPs in osteosarcoma cells comparing to osteoblastic cells Biological Process Protein Percentage of Hits metabolic process (GO:0008152) 29.3 29.3% cellular process (GO:0009987) 20.2 20.2% localization (GO:0051179) 9.4 9.4% biological regulation (GO:0065007) 8 8.0% developmental process (GO:0032502) 7.8 7.8% response to stimulus (GO:0050896) 5.6 5.6% cellular component organization (GO:0071840) 5.6 5.6% multicellular organismal process (GO:0032501) 4.4 4.4% immune system process (GO:0002376) 4.2 4.2% biological adhesion (GO:0022610) 2.7 2.7% apoptotic process (GO:0006915) 1.6 1.6% reproduction (GO:0000003) 0.8 0.8% locomotion (GO:0040011) 0.4 0.4% cell killing (GO:0001906) 0.1 0.1% 100.1% Genes 2179Hits 3870 biological adhesion apoptotic process … reproduction (GO:0000003) , 0.8% (GO:0022610) , 2.7% locomotion (GO:0040011) ,… immune system process cell killing (GO:0001906) , 0.1% (GO:0002376) , 4.2% multicellular organismal process (GO:0032501) , metabolic process 4.4% (GO:0008152) , 29.3% cellular component organization (GO:0071840) , 5.6% response to stimulus (GO:0050896), 5.6% developmental process (GO:0032502) , 7.8% biological regulation (GO:0065007) , 8.0% cellular process (GO:0009987) , 20.2% localization (GO:0051179) , 9.
    [Show full text]
  • Mutations in DCPS and EDC3 in Autosomal Recessive Intellectual
    Human Molecular Genetics, 2015, Vol. 24, No. 11 3172–3180 doi: 10.1093/hmg/ddv069 Advance Access Publication Date: 20 February 2015 Original Article Downloaded from ORIGINAL ARTICLE Mutations in DCPS and EDC3 in autosomal recessive intellectual disability indicate a crucial role for mRNA http://hmg.oxfordjournals.org/ decapping in neurodevelopment Iltaf Ahmed1,2,†, Rebecca Buchert3,†, Mi Zhou5,†, Xinfu Jiao5,†, Kirti Mittal1, Taimoor I. Sheikh1, Ute Scheller3, Nasim Vasli1, Muhammad Arshad Rafiq1, 6 1 7 2 M. Qasim Brohi , Anna Mikhailov , Muhammad Ayaz , Attya Bhatti , at Universitaet Erlangen-Nuernberg, Wirtschafts- und Sozialwissenschaftliche Z on August 15, 2016 Heinrich Sticht4, Tanveer Nasr8,9, Melissa T. Carter10, Steffen Uebe3, André Reis3, Muhammad Ayub7,11, Peter John2, Megerditch Kiledjian5,*, John B. Vincent1,12,13,* and Rami Abou Jamra3,* 1Molecular Neuropsychiatry and Development Lab, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, 250 College Street, Toronto, Ontario, Canada M5T 1R8, 2Atta-ur-Rehman School of Applied Biosciences (ASAB), National University of Sciences and Technology (NUST), Islamabad 44000, Pakistan, 3Institute of Human Genetics and 4Bioinformatics, Institute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen 91054, Germany, 5Department of Cell Biology and Neuroscience, Rutgers University, Piscataway, NJ 08854, USA, 6Sir Cowasji Jehangir Institute of Psychiatry, Hyderabad, Sindh 71000, Pakistan, 7Lahore Institute of Research and Development,
    [Show full text]
  • Dcps Is a Transcript-Specific Modulator of RNA in Mammalian Cells
    Downloaded from rnajournal.cshlp.org on September 28, 2021 - Published by Cold Spring Harbor Laboratory Press DcpS is a transcript-specific modulator of RNA in mammalian cells MI ZHOU,1 SOPHIE BAIL,1 HEATHER L. PLASTERER,2 JAMES RUSCHE,2 and MEGERDITCH KILEDJIAN1 1Department of Cell Biology and Neuroscience, Rutgers University, Piscataway, New Jersey 08854, USA 2Repligen Corporation, Waltham, Massachusetts 02453, USA ABSTRACT The scavenger decapping enzyme DcpS is a multifunctional protein initially identified by its property to hydrolyze the resulting cap structure following 3′ end mRNA decay. In Saccharomyces cerevisiae, the DcpS homolog Dcs1 is an obligate cofactor for the 5′-3′ exoribonuclease Xrn1 while the Caenorhabditis elegans homolog Dcs-1, facilitates Xrn1 mediated microRNA turnover. In both cases, this function is independent of the decapping activity. Whether DcpS and its decapping activity can affect mRNA steady state or stability in mammalian cells remains unknown. We sought to determine DcpS target genes in mammalian cells using a cell-permeable DcpS inhibitor compound, RG3039 initially developed for therapeutic treatment of spinal muscular atrophy. Global mRNA levels were examined following DcpS decapping inhibition with RG3039. The steady-state levels of 222 RNAs were altered upon RG3039 treatment. Of a subset selected for validation, two transcripts that appear to be long noncoding RNAs HS370762 and BC011766, were dependent on DcpS and its scavenger decapping catalytic activity and referred to as DcpS-responsive noncoding transcripts (DRNT) 1 and 2, respectively. Interestingly, only the increase in DRNT1 transcript was accompanied with an increase of its RNA stability and this increase was dependent on both DcpS and Xrn1.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • The Conserved Structure of Plant Telomerase RNA Provides the Missing Link for an Evolutionary Pathway from Ciliates to Humans
    The conserved structure of plant telomerase RNA provides the missing link for an evolutionary pathway from ciliates to humans Jiarui Songa, Dhenugen Logeswaranb,1, Claudia Castillo-Gonzáleza,1, Yang Lib, Sreyashree Bosea, Behailu Birhanu Aklilua, Zeyang Mac,d, Alexander Polkhovskiya,e, Julian J.-L. Chenb,2, and Dorothy E. Shippena,2 aDepartment of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843; bSchool of Molecular Sciences, Arizona State University, Tempe, AZ 85287; cNational Maize Improvement Center of China, China Agricultural University, 100193 Beijing, China; dCollege of Agronomy and Biotechnology, China Agricultural University, 100193 Beijing, China; and eCenter of Life Sciences, Skolkovo Institute of Science and Technology, 121205 Moscow, Russian Federation Edited by Thomas R. Cech, University of Colorado Boulder, Boulder, CO, and approved October 24, 2019 (received for review September 4, 2019) Telomerase is essential for maintaining telomere integrity. Although transcribed by RNA polymerase III (Pol III) (6, 7). The La-related telomerase function is widely conserved, the integral telomerase protein P65 in Tetrahymena recognizes the 3′ poly-U tail of TR RNA (TR) that provides a template for telomeric DNA synthesis has and bends the RNA to facilitate telomerase RNP assembly (8, 9). diverged dramatically. Nevertheless, TR molecules retain 2 highly In contrast, fungi maintain much larger TR molecules (900 to conserved structural domains critical for catalysis: a template- 2,400 nt) that are transcribed by RNA polymerase II (Pol II) (3). proximal pseudoknot (PK) structure and a downstream stem-loop The 3′ end maturation of fungal TRs requires components of the structure. Here we introduce the authentic TR from the plant canonical snRNA biogenesis pathway and results in RNP assembly Arabidopsis thaliana, called AtTR, identified through next-generation sequencing of RNAs copurifying with Arabidopsis TERT.
    [Show full text]
  • Mechanisms of Salmonella Attachment and Survival on In-Shell Black Peppercorns, Almonds, and Hazelnuts
    UC Irvine UC Irvine Previously Published Works Title Mechanisms of Salmonella Attachment and Survival on In-Shell Black Peppercorns, Almonds, and Hazelnuts. Permalink https://escholarship.org/uc/item/5534264q Authors Li, Ye Salazar, Joelle K He, Yingshu et al. Publication Date 2020 DOI 10.3389/fmicb.2020.582202 Peer reviewed eScholarship.org Powered by the California Digital Library University of California fmicb-11-582202 October 19, 2020 Time: 10:46 # 1 ORIGINAL RESEARCH published: 23 October 2020 doi: 10.3389/fmicb.2020.582202 Mechanisms of Salmonella Attachment and Survival on In-Shell Black Peppercorns, Almonds, and Hazelnuts Ye Li1, Joelle K. Salazar2, Yingshu He1, Prerak Desai3, Steffen Porwollik3, Weiping Chu3, Palma-Salgado Sindy Paola4, Mary Lou Tortorello2, Oscar Juarez5, Hao Feng4, Michael McClelland3* and Wei Zhang1* 1 Department of Food Science and Nutrition, Illinois Institute of Technology, Bedford Park, IL, United States, 2 Division of Food Processing Science and Technology, U.S. Food and Drug Administration, Bedford Park, IL, United States, 3 Department of Microbiology and Molecular Genetics, University of California, Irvine, Irvine, CA, United States, 4 Department of Food Science and Human Nutrition, University of Illinois at Urbana-Champaign, Urbana, IL, United States, 5 Department Edited by: of Biology, Illinois Institute of Technology, Chicago, IL, United States Chrysoula C. Tassou, Institute of Technology of Agricultural Products, Hellenic Agricultural Salmonella enterica subspecies I (ssp 1) is the leading cause of hospitalizations and Organization, Greece deaths due to known bacterial foodborne pathogens in the United States and is Reviewed by: frequently implicated in foodborne disease outbreaks associated with spices and nuts.
    [Show full text]
  • Exoribonuclease Nibbler Shapes the 3″ Ends of Micrornas
    Current Biology 21, 1878–1887, November 22, 2011 ª2011 Elsevier Ltd All rights reserved DOI 10.1016/j.cub.2011.09.034 Article The 30-to-50 Exoribonuclease Nibbler Shapes the 30 Ends of MicroRNAs Bound to Drosophila Argonaute1 Bo W. Han,1 Jui-Hung Hung,2 Zhiping Weng,2 precursor miRNAs (pre-miRNAs) [8]. Pre-miRNAs comprise Phillip D. Zamore,1,* and Stefan L. Ameres1,* a single-stranded loop and a partially base-paired stem whose 1Howard Hughes Medical Institute and Department of termini bear the hallmarks of RNase III processing: a two-nucle- Biochemistry and Molecular Pharmacology otide 30 overhang, a 50 phosphate, and a 30 hydroxyl group. 2Program in Bioinformatics and Integrative Biology Nuclear pre-miRNAs are exported by Exportin 5 to the cyto- University of Massachusetts Medical School, plasm, where the RNase III enzyme Dicer liberates w22 nt 364 Plantation Street, Worcester, MA 01605, USA mature miRNA/miRNA* duplexes from the pre-miRNA stem [9–12]. Like all Dicer products, miRNA duplexes contain two- nucleotide 30 overhangs, 50 phosphate, and 30 hydroxyl groups. Summary In flies, Dicer-1 cleaves pre-miRNAs to miRNAs, whereas Dicer-2 converts long double-stranded RNA (dsRNA) into Background: MicroRNAs (miRNAs) are w22 nucleotide (nt) small interfering RNAs (siRNAs), which direct RNA interference small RNAs that control development, physiology, and pathol- (RNAi), a distinct small RNA silencing pathway required for ogy in animals and plants. Production of miRNAs involves the host defense against viral infection and somatic transposon sequential processing of primary hairpin-containing RNA poly- mobilization, as well as gene silencing triggered by exogenous merase II transcripts by the RNase III enzymes Drosha in the dsRNA [13, 14].
    [Show full text]
  • Supplementary Materials
    Supplementary Materials COMPARATIVE ANALYSIS OF THE TRANSCRIPTOME, PROTEOME AND miRNA PROFILE OF KUPFFER CELLS AND MONOCYTES Andrey Elchaninov1,3*, Anastasiya Lokhonina1,3, Maria Nikitina2, Polina Vishnyakova1,3, Andrey Makarov1, Irina Arutyunyan1, Anastasiya Poltavets1, Evgeniya Kananykhina2, Sergey Kovalchuk4, Evgeny Karpulevich5,6, Galina Bolshakova2, Gennady Sukhikh1, Timur Fatkhudinov2,3 1 Laboratory of Regenerative Medicine, National Medical Research Center for Obstetrics, Gynecology and Perinatology Named after Academician V.I. Kulakov of Ministry of Healthcare of Russian Federation, Moscow, Russia 2 Laboratory of Growth and Development, Scientific Research Institute of Human Morphology, Moscow, Russia 3 Histology Department, Medical Institute, Peoples' Friendship University of Russia, Moscow, Russia 4 Laboratory of Bioinformatic methods for Combinatorial Chemistry and Biology, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia 5 Information Systems Department, Ivannikov Institute for System Programming of the Russian Academy of Sciences, Moscow, Russia 6 Genome Engineering Laboratory, Moscow Institute of Physics and Technology, Dolgoprudny, Moscow Region, Russia Figure S1. Flow cytometry analysis of unsorted blood sample. Representative forward, side scattering and histogram are shown. The proportions of negative cells were determined in relation to the isotype controls. The percentages of positive cells are indicated. The blue curve corresponds to the isotype control. Figure S2. Flow cytometry analysis of unsorted liver stromal cells. Representative forward, side scattering and histogram are shown. The proportions of negative cells were determined in relation to the isotype controls. The percentages of positive cells are indicated. The blue curve corresponds to the isotype control. Figure S3. MiRNAs expression analysis in monocytes and Kupffer cells. Full-length of heatmaps are presented.
    [Show full text]
  • Ribonuclease E Organizes the Protein Interactions in the Escherichia Coli RNA Degradosome
    Downloaded from genesdev.cshlp.org on September 26, 2021 - Published by Cold Spring Harbor Laboratory Press Ribonuclease E organizes the protein interactions in the Escherichia coli RNA degradosome Nathalie F. Vanzo,1 Yeun Shan Li,2 Be´atrice Py,2,3 Erwin Blum,2 Christopher F. Higgins,2,4 Lelia C. Raynal,1 Henry M. Krisch,1 and Agamemnon J. Carpousis1,5 1Laboratoire de Microbiologie et Ge´ne´tique Mole´culaire, UPR 9007, Centre National de la Recherche Scientifique (CNRS), 31062 Toulouse Cedex, France; 2Nuffield Department of Clinical Biochemistry and Imperial Cancer Research Fund Laboratories, Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DS, UK The Escherichia coli RNA degradosome is the prototype of a recently discovered family of multiprotein machines involved in the processing and degradation of RNA. The interactions between the various protein components of the RNA degradosome were investigated by Far Western blotting, the yeast two-hybrid assay, and coimmunopurification experiments. Our results demonstrate that the carboxy-terminal half (CTH) of ribonuclease E (RNase E) contains the binding sites for the three other major degradosomal components, the DEAD-box RNA helicase RhlB, enolase, and polynucleotide phosphorylase (PNPase). The CTH of RNase E acts as the scaffold of the complex upon which the other degradosomal components are assembled. Regions for oligomerization were detected in the amino-terminal and central regions of RNase E. Furthermore, polypeptides derived from the highly charged region of RNase E, containing the RhlB binding site, stimulate RhlB activity at least 15-fold, saturating at one polypeptide per RhlB molecule. A model for the regulation of the RhlB RNA helicase activity is presented.
    [Show full text]
  • Characterization of the Mammalian RNA Exonuclease 5/NEF-Sp As a Testis-Specific Nuclear 3′′′′′ → 5′′′′′ Exoribonuclease
    Downloaded from rnajournal.cshlp.org on October 7, 2021 - Published by Cold Spring Harbor Laboratory Press Characterization of the mammalian RNA exonuclease 5/NEF-sp as a testis-specific nuclear 3′′′′′ → 5′′′′′ exoribonuclease SARA SILVA,1,2 DAVID HOMOLKA,1 and RAMESH S. PILLAI1 1Department of Molecular Biology, University of Geneva, CH-1211 Geneva 4, Switzerland 2European Molecular Biology Laboratory, Grenoble Outstation, 38042, France ABSTRACT Ribonucleases catalyze maturation of functional RNAs or mediate degradation of cellular transcripts, activities that are critical for gene expression control. Here we identify a previously uncharacterized mammalian nuclease family member NEF-sp (RNA exonuclease 5 [REXO5] or LOC81691) as a testis-specific factor. Recombinant human NEF-sp demonstrates a divalent metal ion-dependent 3′′′′′ → 5′′′′′ exoribonuclease activity. This activity is specific to single-stranded RNA substrates and is independent of their length. The presence of a 2′′′′′-O-methyl modification at the 3′′′′′ end of the RNA substrate is inhibitory. Ectopically expressed NEF-sp localizes to the nucleolar/nuclear compartment in mammalian cell cultures and this is dependent on an amino-terminal nuclear localization signal. Finally, mice lacking NEF-sp are viable and display normal fertility, likely indicating overlapping functions with other nucleases. Taken together, our study provides the first biochemical and genetic exploration of the role of the NEF-sp exoribonuclease in the mammalian genome. Keywords: NEF-sp; LOC81691; Q96IC2; REXON; RNA exonuclease 5; REXO5; 2610020H08Rik INTRODUCTION clease-mediated processing to create their final 3′ ends: poly(A) tails of most mRNAs or the hairpin structure of Spermatogenesis is the process by which sperm cells are replication-dependent histone mRNAs (Colgan and Manley produced in the male germline.
    [Show full text]
  • Identification of Enhancer of Mrna Decapping 4 As a Novel Fusion Partner of MLL in Acute Myeloid Leukemia
    STIMULUS REPORT Identification of enhancer of mRNA decapping 4 as a novel fusion partner of MLL in acute myeloid leukemia Heiko Becker,1-3 Gabriele Greve,1,2 Keisuke Kataoka,4 Jan-Philipp Mallm,5,6 Jesus´ Duque-Afonso,1,2,7 Tobias Ma,1,2 Christoph Niemoller,¨ 1,2 Milena Pantic,1 Justus Duyster,1-3 Michael L. Cleary,7 Julia Schuler,¨ 8 Karsten Rippe,5,6 Seishi Ogawa,3 and Michael Lubbert¨ 1-3 1Department of Medicine I, Medical Center, and 2Faculty of Medicine, University of Freiburg, Freiburg, Germany; 3German Cancer Consortium partner site, Freiburg, Germany; 4Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan; 5Division of Chromatin Networks and 6Single-cell Open Laboratory, German Cancer Research Center, Heidelberg, Germany; 7Department of Pathology, Stanford University, Stanford, CA; and 8Charles River Discovery Research Services Germany GmbH, Freiburg, Germany Key Points Introduction • mRNA decapping gene Translocations involving MLL (aka KMT2A) located on chromosome 11q23 occur in acute myeloid EDC4 is a novel fusion leukemia (AML) and lymphoblastic leukemia. In AML, they generally confer an adverse prognosis, unless MLL partner of in AML. the MLLT3 (aka AF9) gene is involved.1 More than 130 different translocation partner genes (TPGs) MLL 2 • Genes functioning in have been identified, forming the recombinome. mRNA decapping may Recently, the scavenger messenger RNA (mRNA) decapping enzyme DCPS has been identified to be compose a distinct required for survival of AML cells, but not normal hematopoietic cells, and a DCPS inhibitor showed antileukemic activity.3,4 DCPS is also 1 of 2 genes (the other being DCP1A) involved in mRNA group of MLL fusion decapping and having been described as TPG of MLL in single leukemia cases.5-7 partners that links MLL MLL function with mRNA Here, we describe a novel fusion with another mRNA decapping component, ie, the enhancer of mRNA decapping 4 gene (EDC4;alsoknownasGE1 or HEDLS), in AML.
    [Show full text]
  • The Structure and Function of the Gram-Positive Bacterial RNA Degradosome
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Frontiers - Publisher Connector REVIEW published: 03 February 2017 doi: 10.3389/fmicb.2017.00154 The Structure and Function of the Gram-Positive Bacterial RNA Degradosome Kyu Hong Cho* Department of Biology, Indiana State University, Terre Haute, IN, USA The RNA degradosome is a highly structured protein complex responsible for bulk RNA decay in bacteria. The main components of the complex, ribonucleases, an RNA helicase, and glycolytic enzymes are well-conserved in bacteria. Some components of the degradosome are essential for growth and the disruption of degradosome formation causes slower growth, indicating that this complex is required for proper cellular function. The study of the Escherichia coli degradosome has been performed extensively for the last several decades and has revealed detailed information on its structure and function. On the contrary, the Gram-positive bacterial degradosome, which contains ribonucleases different from the E. coli one, has been studied only recently. Studies on the Gram-positive degradosome revealed that its major component RNase Y was necessary for the full virulence of medically important Gram-positive bacterial pathogens, Edited by: suggesting that it could be a target of antimicrobial therapy. This review describes the Marc Bramkamp, Ludwig Maximilian University of structures and function of Gram-positive bacterial RNA degradosomes, especially those Munich, Germany of a Gram-positive model organism Bacillus subtilis, and two important Gram-positive Reviewed by: pathogens, Staphylococcus aureus and Streptococcus pyogenes. Jörg Stülke, University of Göttingen, Germany Keywords: Gram-positive RNA degradosome, B. subtilis, S.
    [Show full text]